trastuzumab deruxtecan for the treatment of her2 breast cancer
Published 4 years ago • 3K plays • Length 5:59Download video MP4
Download video MP3
Similar videos
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases
-
4:30
tucatinib for the treatment of her2 breast cancer
-
8:42
trastuzumab deruxtecan in her2 breast cancer
-
7:45
trastuzumab emtansine in her2 breast cancer
-
0:46
clinical trials remain underway for trastuzumab deruxtecan in her2-positive breast cancer
-
4:01
trastuzumab deruxtecan: a promising agent for treating her2-low breast cancer?
-
1:39
pfs data support approval of fam-trastuzumab deruxtecan-nxki for her2 breast cancer
-
3:19
study of targeted therapy for her2-positive metastatic breast cancer
-
2:12
trastuzumab deruxtecan in her2-low advanced breast cancer | nejm
-
47:29
optimizing therapy in her2 disease with dr. reshma mahtani
-
0:59
sequencing her2-targeted therapies in breast cancer
-
27:03
antibody drug conjugates: the end of chemotherapy | 2023 west oncology conference
-
2:21
adcs for the treatment of her2-low breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
1:16
the optimal duration of pertuzumab treatment for patients with her2 breast cancer
-
1:31
current treatment options for patients with her2-positive metastatic breast cancer
-
6:40
her2 breast cancer: managing patients on t-dm1
-
3:32
sequencing novel her2-targeted therapies in metastatic breast cancer
-
5:40
trastuzumab deruxtecan doubles pfs in metastatic breast cancer with low her2 expression